Decoy Therapeutics Inc. (DCOY): Cash & Equivalents
$10.71M
As of 2025-12-31
$8.29M
As of 2026-06-30
-4.0%
3-year compound annual growth
-0.7%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.71M | +339.9% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $2.43M | -58.7% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $5.90M | -51.3% | 2025-03-21, Balance as of period end |
| 2022-12-31 | $12.11M | -58.6% | 2024-03-22, Balance as of period end |
| 2021-12-31 | $29.21M | +162.8% | 2023-03-27, Balance as of period end |
| 2020-12-31 | $11.12M | +197.4% | 2022-03-25, Balance as of period end |
| 2019-12-31 | $3.74M | +15.8% | 2021-03-18, Balance as of period end |
| 2018-12-31 | $3.23M | -83.2% | 2020-03-23, Balance as of period end |
| 2017-12-31 | $19.19M | n/a | 2019-03-06, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $10.71M | +339.9% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $4.42M | -41.1% |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | $6.35M | +124.0% |
| MetaVia Inc. (MTVA) | 2025-12-31 | $10.28M | -35.8% |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $2.20M | +238.6% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $5.00M | n/a |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $10.70M | +64.6% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $334.0K | -82.6% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $4.66M | -75.8% |
Compare DCOY, LTRN, MIRA, MTVA side by side · Screen every company in Pharmaceutical Preparations ↗